全文获取类型
收费全文 | 270393篇 |
免费 | 18813篇 |
国内免费 | 19679篇 |
专业分类
耳鼻咽喉 | 2563篇 |
儿科学 | 3280篇 |
妇产科学 | 2788篇 |
基础医学 | 28313篇 |
口腔科学 | 5505篇 |
临床医学 | 32669篇 |
内科学 | 29043篇 |
皮肤病学 | 4628篇 |
神经病学 | 5703篇 |
特种医学 | 7195篇 |
外国民族医学 | 385篇 |
外科学 | 16578篇 |
综合类 | 78848篇 |
预防医学 | 12573篇 |
眼科学 | 3647篇 |
药学 | 28447篇 |
383篇 | |
中国医学 | 17267篇 |
肿瘤学 | 29070篇 |
出版年
2024年 | 2175篇 |
2023年 | 6907篇 |
2022年 | 8413篇 |
2021年 | 9332篇 |
2020年 | 7295篇 |
2019年 | 7336篇 |
2018年 | 4285篇 |
2017年 | 6457篇 |
2016年 | 7475篇 |
2015年 | 8152篇 |
2014年 | 11644篇 |
2013年 | 11941篇 |
2012年 | 16364篇 |
2011年 | 18193篇 |
2010年 | 16693篇 |
2009年 | 17307篇 |
2008年 | 19525篇 |
2007年 | 17085篇 |
2006年 | 16490篇 |
2005年 | 16824篇 |
2004年 | 13824篇 |
2003年 | 11626篇 |
2002年 | 9334篇 |
2001年 | 8413篇 |
2000年 | 6747篇 |
1999年 | 5414篇 |
1998年 | 4307篇 |
1997年 | 3697篇 |
1996年 | 3156篇 |
1995年 | 2702篇 |
1994年 | 2343篇 |
1993年 | 1498篇 |
1992年 | 1453篇 |
1991年 | 1298篇 |
1990年 | 1047篇 |
1989年 | 1125篇 |
1988年 | 332篇 |
1987年 | 225篇 |
1986年 | 201篇 |
1985年 | 126篇 |
1984年 | 59篇 |
1983年 | 15篇 |
1982年 | 18篇 |
1981年 | 11篇 |
1980年 | 8篇 |
1979年 | 5篇 |
1977年 | 2篇 |
1976年 | 5篇 |
1958年 | 1篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
目的 探讨肾癌组织中血管内皮生长因子的表达及其与肾癌生物学行为的关系。方法 应用单克隆鼠抗-VEGF抗体通过免疫组化SP法研究肾癌中血管内皮生长因子的表达。结果 60例肾癌组织中35例(58.3%)血管内皮生长因子阳性。血表达与组织学分级(P<0.05)和TNM分期(P<0.05)均明显相关。 结论 血管内皮生长因子表达对肾癌生物学行为有重要影响,设法抑制血管内皮生长因子有望成为肾癌治疗的另一有效方法。 相似文献
992.
BACKGROUND: The treatment of diffuse brain injury during an acute period is focused on relieving degrees of secondary brain injury. Generation and development of pathological changes of secondary brain injury depend on signal conduction, so down-regulating over response of astrocyte through interfering a key link of signal conduction pathway may bring a new thinking for the treatment of diffuse brain injury.
OBJECTIVE: To observe the effect of over activity of extracellular signal regulated kinases 1/2 (ERK1/2) signal pathway on the response of astrocyte during an acute period of diffuse brain injury.
DESIGN: Completely randomized grouping and controlled animal study.
SETTINGS: Department of Neurosurgery, the Third Affiliated Hospital, Nanchang University; Department of Neurosurgery, Union Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology.
MATERIALS: A total of 158 healthy male SD rats, of 11 weeks old, weighing 320–370 g, were provided by Experimental Animal Faulty, Tongji Medical College, Huazhong University of Science and Technology. Rabbit-anti-phosphorylated ERK1/2 (pERK1/2) polyclonal antibody was provided by R&D Company; rabbit-anti-glial fibrillary acidic protein (GFAP) polyclonal antibody, SP immunohistochemical kit and horseradish peroxidase (HRP)-labeled goat-anti-rabbit IgG by Santa Cruz Company; specific inhibitor U0126 of ERK1/2 signal pathway by Alexis Company.
METHODS: The experiment was carried out in the Laboratory of Neurosurgery, Union Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology from September 2004 to March 2006. ① Detection of pERK1/2 expression: A total of 110 rats were randomly divided into sham operation group (n =5), model group (n =35), high-dosage U0126 group (n =35) and low-dosage U0126 group (n =35). Rats in the sham operation group were only treated with incision of epicranium and fixation of backup plate, but not hit. Rats in the model group were used to establish diffuse brain injury models based on Marmarou free falling body without drug intervention. Rats in the high- and low-dosage U0126 groups were injected into caudal vein with 0.1 and 0.05 mg/kg U0126, respectively, and then, rats were hit to establish injured models. Every 5 rats were collected from model, high- and low-dosage U0126 groups at 5, 30 minutes, 3, 12, 24, 72 hours and 7 days after diffuse brain injury to detect pERK1/2 expression in cortex of parietal lobe based on Western blot technique. ② Distribution of pERK1/2 and positive GFAP cells in brain tissue: Another 48 rats were randomly divided into sham operation group (n =3), model group (n =15), high-dosage U0126 group (n =15) and low-dosage U0126 group (n =15). The intervention and administration were dealt as the same as those mentioned above. Every 3 rats were collected from model, high- and low-dosage U0126 groups at 30 minutes, 3, 12, 24 and 72 hours after model establishment to observe the distribution of pERK1/2 and postive GFAP cells in brain tissue which was cut from coronal section at Bregma –4.8 mm layer with immunohistochemical staining.
MAIN OUTCOME MEASURES: pERK1/2 expression in cortex of parietal lobe and distribution of pERK1/2 and positive GFAP cells in brain tissues.
RESULTS: ① pERK1/2 expression: After diffuse brain injury, pERK1/2 expression in cortex of parietal lobe was rapidly increased in the model group, reached at peak at 5 minutes and then decreased gradually. But the expression was still in a high level until the 72nd hour and fallen to the basic level on the 7th day. pERK1/2 level was lower in high- and low-dosage U0126 groups than that in model group at various time points (P < 0.01); meanwhile, pERK1/2 level was lower in high-dosage U0126 group than that in low-dosage U0126 group. The results showed that there was a certain dosage dependence on pERK1/2 expression. ② Distribution of pERK1/2 and positive GFAP cells in brain tissue: Positive expression of pERK1/2 lasted in brain tissue from 30 minutes to 72 hours after diffuse brain injury (P < 0.05). In addition, from 30 minutes to 3 hours, brown-yellow stained cells were mainly distributed in plasma, but rarely in nucleus. A lot of positive cells had tree-like apophysis, which was similar to neurons. With the time passing by, more and more nuclei manifested positive stains; moreover, nuclei mainly manifested positive staining until 24 hours after diffuse brain injury. Immune-positive pERK1/2 cells were widely distributed in brain tissue, especially mainly in binding site between deep cortex and cerebral white matter, and then in hippocampus. In addition, ependymal cell and vascular endothelial cells of choroids plexus also manifested strongly positive staining. As compared with model group, positive cells were decreased gradually in high- and low-dosage U0126 groups. However, number of positive cells was less in high-dosage U0126 group than that in low-dosage U0126 group.
CONCLUSION: Diffuse brain injury strongly induces the activity of ERK1/2 signal pathway and response of astrocyte; in addition, U0126 can inhibit response of glial cells during an acute period, and the effect manifests dosage dependence. 相似文献
993.
近年来在研究HCV与易感细胞的相互作用中发现 ,血清中的HCV颗粒是与 β 脂蛋白或IgG结合形成复合物(HCV RNAcarryingmaterial,HCVrcm ) ,HCVrcm通过与细胞表面的脂蛋白受体分子结合进入细胞 ,这种复合物的形成有利于HCV与靶细胞的结合和HCV的持续感染。人低密度脂蛋白受体(hLDLR)是一种表达在细胞表面的脂蛋白受体分子 ,是HCV感染细胞的重要受体 ,它在介导LDL进入细胞的过程中同时将HCV带入胞内。HCV能感染人的肝脏细胞 ,但是不能感染小鼠的肝脏细胞 ,分析可能原因是小鼠的肝脏细胞表面的小鼠低密度脂基金项目 :国家自然科… 相似文献
994.
995.
幽门螺杆菌感染及其毒力因子和胃十二指肠疾病关系的研究 总被引:9,自引:0,他引:9
目的 探讨幽门螺杆菌(Hp)感染病人中Hp细胞毒相关蛋白(CagA)、细胞空泡毒素(VacA)抗体在胃十二指肠疾病的比例,并评估不同类型幽门螺杆菌感染对胃窦粘膜炎症程度的影响。方法 应用免疫印迹法测定Hp感染者病人体内的CagA、VacA抗体。结果 73%的Hp感染者病人中出现CagA抗体,61%Hp感染者病人中出现VacA抗体。CagA抗体和VacA抗体在各疾病之间差异无显著性(P>0.05)。在胃溃疡、十二指肠溃疡和复合性溃疡三类病人中,具CagA和VacA双阳性的比例较CagA和VacA双阴性的比例差异有显著性(P<0.05)。胃窦萎缩病变在CagA和VacA双阳性的病人中比CagA和VacA双阴性的病人严重(P<0.05)。结论 具有高毒力因子(CagA和VacA)的Hp是胃肠疾病病人感染的常见菌株,具有CagA和VacA的Hp可能在诱导胃粘膜发展到萎缩病变过程中起重要作用。但不能作为特异性指标来判断胃十二指肠疾病。 相似文献
996.
目的:探讨支气管哮喘患者CD8+T细胞对单核/巨噬细胞抗原递呈功能的影响。方法:哮喘患者20例,健康对照22例,分别取静脉血5 mL,并分离MΦ、CD8+T细胞和B细胞。每份血样分成4组:MΦ递呈抗原组、CD8+T细胞参与MΦ递呈抗原组、CD8+T细胞体外活化后对MΦ递呈抗原影响组及自然状态下CD8+T细胞对MΦ细胞递呈抗原影响组。各组用CTLL2P抗原刺激18 h后,洗去刺激原,与自体B细胞共同孵育10 d,吸取上清液,测定特异性IgM、IgE、IgG含量。
结果:①哮喘患者MΦ单独递呈抗原,自体B细胞特异性IgM(A490值)(0.034±0.022)明显低于健康人(0.116±0.080)(P<0.05);CD8+T细胞与MΦ共同培养递呈抗原时,产生的特异性IgM(A490值)(0.031±0.021)低于健康人(0.079±0.064)(P<0.05);②哮喘患者CD8+T细胞与MΦ共同培养递呈抗原时,产生的特异性IgG(A490值)(0.102±0.041)明显高于健康人(0.081±0.067)(P<0.05),自然状态下及体外活化后CD8+T细胞与递呈抗原MΦ共同培养,产生的特异性IgG(A490值)(0.105±0.066, 0.079±0.059)与健康人(0.066±0.038, 0.069±0.047)无明显差别(P>0.05);③哮喘患者CD8+T细胞与MΦ共同培养递呈抗原产生的特异性IgE(A490值)(0.171±0.154)高于健康人(0.147±0.059)(P<0.05)。
结论:哮喘患者CD8+T细胞对MΦ递呈抗原产生免疫球蛋白有调节作用,而且参与哮喘发病。 相似文献
997.
998.
凋亡是一种主动方式的程序性细胞死亡 ,它的形态特征为细胞固缩、核碎裂。近来 Majno提出一种表现为细胞肿胀和核溶解的细胞损伤过程 ,称之为胀亡 (oncosis)。目前 ,毒理病理学家认为凋亡和胀亡代表了两种不同的细胞死亡方式。本文对细胞胀亡的病理形态特征、生化改变和发生机制、分子调控的初步研究进展及其与凋亡的联系进行综述 ,以利于加深对细胞死亡方式的进一步认识 相似文献
999.
中药安迪对HL-60细胞分化的诱导作用 总被引:4,自引:1,他引:3
目的 探讨安迪粉针剂 (Andi)对 HL- 60细胞分化的诱导作用 .方法 采用人早幼粒白血病细胞株 (HL - 60 )为靶细胞 ,分为不加任何药物的对照组 (C组 )、安迪粉针剂 (Andi)组、阳性对照药维甲酸 (RA)组和苦参 (KS)组 ,进行体外培养和诱导分化 ,观测细胞生长曲线、细胞形态、硝基蓝四氮唑(NBT)还原和吞噬能力等指标 .结果 2 mg· L-1 Andi可显著地抑制 HL - 60细胞增殖 ,使原始细胞分化为中幼以下的成熟细胞 ,分化后的细胞具有 NBT还原能力和吞噬功能 ;Andi为 68.0 % ,RA为 61 .5% ,KS为 59.0 % ,C组还原能力仅6.0 % (P<0 .0 1 vs C) .其形态的改变和吞噬能力与阳性对照药维甲酸 (RA)和苦参 (KS)相似 ,分别为 52 .0 % ,45.5%和56.5% (P>0 .0 5) ;均明显高于空白对照组 .C组吞噬功能仅7.5% (P <0 .0 1 vs C)其 NBT还原能力与 KS相当 (P >0 .0 5) .结论 Andi对 HL - 60细胞具有显著的诱导分化作用 相似文献
1000.